Related Experiment Video
Updated: Nov 21, 2025
11:28
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
10.6K
Gelatin-Based 3D Microgels for In Vitro T Lineage Cell Generation
Anisha B Suraiya1,2, Michael L Hun2, Vinh X Truong1
1Department of Materials Science and Engineering, Monash Institute of Medical Engineering, Monash University, Wellington Road, Clayton, Melbourne 3800, Australia.
ACS Biomaterials Science & Engineering
|January 18, 2021
Summary
Generating naive T cells is crucial for adaptive immunity and cancer therapy. A new 3D microgel system effectively supports T cell development and thymic epithelial cell maintenance, offering a scalable alternative to 2D cultures.
Area of Science:
- Immunology
- Biotechnology
- Regenerative Medicine
Background:
- T cells are vital for adaptive immunity and cancer immunotherapy.
- Thymic involution with age limits naive T cell production, necessitating new generation strategies.
- Current 2D culture methods lack physiological relevance and scalability.
Purpose of the Study:
- To develop and evaluate a novel 3D microgel system for in vitro T cell generation.
- To assess the capacity of the 3D system for maintaining thymic epithelial cell (TEC) phenotype and function.
- To explore the potential for scalable T cell production using this 3D approach.
Main Methods:
- Co-culture of OP9-DL4 cells and hematopoietic stem cells (HSCs) within a gelatin-based 3D microgel.
- Encapsulation of mouse embryonic thymic epithelial cells (TECs) within the microgels.
- Flow cytometry analysis to assess T lineage induction and TEC phenotype.
Main Results:
- The 3D microgel system supported T lineage induction comparable to 2D cultures.
- The microgels successfully maintained TEC phenotype and function.
- The system demonstrated potential for scalable T cell generation.
Conclusions:
- The 3D microgel system provides a physiologically relevant and scalable platform for T cell generation.
- This approach holds promise for addressing the limitations of thymic involution and advancing T cell-based therapies.
